{"id":"https://openalex.org/W4367304386","doi":"https://doi.org/10.1212/wnl.0000000000201898","title":"Evaluating the Effect of Sodium Phenylbutyrate and Taurursodiol on Survival Outcomes in Amyotrophic Lateral Sclerosis Using a Propensity Score\u2013Matched Cohort From the Pooled Resource Open-Access ALS Clinical Trials (PRO-ACT) Database (S33.005)","display_name":"Evaluating the Effect of Sodium Phenylbutyrate and Taurursodiol on Survival Outcomes in Amyotrophic Lateral Sclerosis Using a Propensity Score\u2013Matched Cohort From the Pooled Resource Open-Access ALS Clinical Trials (PRO-ACT) Database (S33.005)","publication_year":2023,"publication_date":"2023-04-25","ids":{"openalex":"https://openalex.org/W4367304386","doi":"https://doi.org/10.1212/wnl.0000000000201898"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.0000000000201898","doi":"https://doi.org/10.1212/wnl.0000000000201898","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.0000000000201898","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018168468","display_name":"Sabrina Paganoni","orcid":"https://orcid.org/0000-0003-0505-1168","observed_orcids":["https://orcid.org/0000-0003-0505-1168"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sabrina Paganoni","raw_affiliation_strings":["Sean M. Healey and AMG Center for ALS & the Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sean M. Healey and AMG Center for ALS & the Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073802129","display_name":"Melanie Quintana","orcid":"https://orcid.org/0000-0002-1763-2704","observed_orcids":["https://orcid.org/0000-0002-1763-2704"]},"institutions":[{"id":"https://openalex.org/I4405267949","display_name":"Berry Consultants, LLC (United States)","ror":"https://ror.org/054btrt70","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267949"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melanie Quintana","raw_affiliation_strings":["Berry Consultants, LLC, Austin, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Berry Consultants, LLC, Austin, TX, USA","institution_ids":["https://openalex.org/I4405267949"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013541231","display_name":"Yuehui Wu","orcid":"https://orcid.org/0000-0003-2239-8913","observed_orcids":["https://orcid.org/0000-0003-2239-8913","https://orcid.org/0000-0002-7645-5920"]},"institutions":[{"id":"https://openalex.org/I4405267609","display_name":"Amylyx Pharmaceuticals, Inc. (United States)","ror":"https://ror.org/03hngf113","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267609"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yuehui Wu","raw_affiliation_strings":["Amylyx Pharmaceuticals, Inc., Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylyx Pharmaceuticals, Inc., Cambridge, MA, USA","institution_ids":["https://openalex.org/I4405267609"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004158980","display_name":"Jamie Timmons","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267609","display_name":"Amylyx Pharmaceuticals, Inc. (United States)","ror":"https://ror.org/03hngf113","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267609"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jamie Timmons","raw_affiliation_strings":["Amylyx Pharmaceuticals, Inc., Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylyx Pharmaceuticals, Inc., Cambridge, MA, USA","institution_ids":["https://openalex.org/I4405267609"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044584675","display_name":"Merit Cudkowicz","orcid":"https://orcid.org/0000-0002-7075-1681","observed_orcids":["https://orcid.org/0000-0002-7075-1681"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Merit Cudkowicz","raw_affiliation_strings":["Sean M. Healey and AMG Center for ALS & the Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sean M. Healey and AMG Center for ALS & the Neurological Clinical Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"100","issue":"17_supplement_2","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10855","display_name":"Amyotrophic Lateral Sclerosis Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10855","display_name":"Amyotrophic Lateral Sclerosis Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/amyotrophic-lateral-sclerosis","display_name":"amyotrophic lateral sclerosis","score":0.9359999895095825},{"id":"https://openalex.org/keywords/4-phenylbutyrate","display_name":"4-phenylbutyric acid","score":1.0},{"id":"https://openalex.org/keywords/open-label-extension","display_name":"open-label extension","score":0.8870000243186951},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.878000020980835},{"id":"https://openalex.org/keywords/historical-control-comparison","display_name":"historical control comparison","score":0.5690000057220459},{"id":"https://openalex.org/keywords/pro-act-database","display_name":"PRO-ACT database","score":0.8880000114440918},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.44999998807907104},{"id":"https://openalex.org/keywords/bile-acid-sequestrants","display_name":"bile acid sequestrants","score":0.5979999899864197},{"id":"https://openalex.org/keywords/amino-acid-catabolism","display_name":"amino acid catabolism","score":0.5099999904632568},{"id":"https://openalex.org/keywords/trial-design-bias","display_name":"trial design bias","score":0.4169999957084656},{"id":"https://openalex.org/keywords/generalizability","display_name":"generalizability","score":0.3089999854564667}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7687515020370483},{"id":"https://openalex.org/C2780596555","wikidata":"https://www.wikidata.org/wiki/Q206901","display_name":"Amyotrophic lateral sclerosis","level":3,"score":0.691927433013916},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6467491388320923},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.6439011096954346},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6231905817985535},{"id":"https://openalex.org/C17923572","wikidata":"https://www.wikidata.org/wiki/Q7250160","display_name":"Propensity score matching","level":2,"score":0.598879337310791},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5255438685417175},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.5066648125648499},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5025238990783691},{"id":"https://openalex.org/C67761136","wikidata":"https://www.wikidata.org/wiki/Q2105849","display_name":"Post-hoc analysis","level":2,"score":0.4810483753681183},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.47242724895477295},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4100538492202759},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.33787572383880615},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.16670361161231995},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.12125095725059509},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.09622976183891296},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1212/wnl.0000000000201898","doi":"https://doi.org/10.1212/wnl.0000000000201898","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.0000000000201898","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4387439424","https://openalex.org/W4229000223","https://openalex.org/W3092893535","https://openalex.org/W4280584569","https://openalex.org/W4205984616","https://openalex.org/W7164738237","https://openalex.org/W4380149587","https://openalex.org/W3082122716","https://openalex.org/W4379207455","https://openalex.org/W4388846613"],"abstract_inverted_index":{"Objective:":[0],"To":[1],"assess":[2],"the":[3,16,49,120,207,308,326,344,362,380,570,588,606,625,643,661,679,697,715,733,751,769,787,805,824,842,860,878,896,914,932,957,981,993,1008],"potential":[4],"effect":[5],"of":[6,116,136,139,201,209,261,310,328,346,364,382,394,405,416,427,438,449,460,471,482,493,504,515,541,560,572,590,608,627,645,663,681,699,717,735,753,771,789,807,826,844,862,880,898,916,934,959,983,992,995,1010,1026,1033,1042,1053,1065,1076,1088,1099,1111,1122,1134,1145],"placebo-to-active":[7,130,296],"crossover":[8,131,297],"on":[9,273,938,963],"intent-to-treat":[10],"(ITT)":[11],"overall":[12],"survival":[13,93,137,159,235,267,279],"results":[14,260],"from":[15,48,170,178,187,244,401,412,423,434,445,456,467,478,489,500,511,522,1049,1060,1072,1083,1095,1106,1118,1129,1141,1152,1160],"CENTAUR":[17,64,179,188,214,245],"trial":[18,81],"evaluating":[19],"an":[20,41,149,539,558,988,1015],"oral,":[21],"fixed-dose":[22],"sodium":[23],"phenylbutyrate":[24],"and":[25,71,123,180,190],"taurursodiol":[26],"combination":[27],"(PB&TURSO)":[28],"in":[29,95,142,161,213,241,276,284,298,307,325,343,361,379,547,569,587,605,624,642,660,678,696,714,732,750,768,786,804,823,841,859,877,895,913,931,956,980,1007,1038],"amyotrophic":[30],"lateral":[31],"sclerosis":[32],"(ALS),":[33],"a":[34,59,66,72,89,220,265,315,333,351,369,387,577,595,613,632,650,668,686,704,722,740,758,776,794,812,831,849,867,885,903,921,939,964,1161],"post":[35],"hoc":[36],"analysis":[37,79,263,275,286],"was":[38,215,237],"performed":[39],"utilizing":[40],"external,":[42],"propensity":[43,196],"score\u2013matched":[44],"(PSM),":[45],"PB&TURSO-na\u00efve":[46],"cohort":[47],"Pooled":[50],"Resource":[51],"Open-Access":[52],"ALS":[53,1130],"Clinical":[54],"Trials":[55],"(PRO-ACT)":[56],"database":[57],"as":[58,314,332,350,368,386,538,557,576,594,612,631,649,667,685,703,721,739,757,775,793,811,830,848,866,884,902,920,987,1014],"historical":[60,171,191,249],"control":[61,151,168,192],"comparator.":[62],"Background:":[63],"encompassed":[65],"6-month":[67],"randomized":[68,98],"placebo-controlled":[69],"phase":[70,122],"long-term":[73],"open-label":[74],"extension":[75],"(OLE)":[76],"phase.":[77],"ITT":[78,274],"at":[80],"conclusion":[82],"(maximum":[83],"postrandomization":[84],"follow-up,":[85],"44":[86],"months)":[87,247],"showed":[88],"4.8-month":[90],"longer":[91,240],"median":[92],"time":[94],"those":[96],"originally":[97],"to":[99,126,134,282,528,1164],"PB&TURSO":[100,270,283],"(23.5":[101],"mo)":[102],"versus":[103,248],"placebo":[104],"(18.7":[105],"mo;":[106],"hazard":[107],"ratio":[108],"[HR]=0.64;":[109],"95%":[110,254],"CI,":[111,255],"0.42\u20131.00;":[112],"P=.048).":[113],"Notably,":[114],"71%":[115],"placebo-randomized":[117],"participants":[118,166,186,193,243],"entered":[119],"OLE":[121],"crossed":[124],"over":[125],"active":[127],"treatment.":[128],"Such":[129],"may":[132,153],"lead":[133],"underestimation":[135],"benefit":[138,268,280],"investigational":[140],"therapies":[141],"trials":[143,172],"incorporating":[144],"this":[145,162,262,285],"design.":[146],"Comparison":[147],"with":[148,269,288],"external":[150],"group":[152],"provide":[154],"additional":[155],"context":[156],"beyond":[157],"observed":[158],"outcomes":[160],"setting.":[163],"Design/Methods:":[164],"PRO-ACT":[165],"were":[167,195,228],"subjects":[169],"who":[173],"met":[174],"major":[175],"enrollment":[176],"criteria":[177],"had":[181],"known":[182],"mortality":[183],"information.":[184],"PB&TURSO-randomized":[185,242],"(n=89)":[189],"(n=85)":[194],"score":[197],"matched":[198],"using":[199,219,291],"covariates":[200,227],"prognostic":[202],"significance.":[203],"Survival":[204],"probability":[205],"through":[206],"date":[208],"final":[210],"participant":[211],"visit":[212],"compared":[216],"between":[217,232],"groups":[218],"Cox":[221],"proportional":[222],"hazards":[223],"model.":[224],"Results:":[225],"PSM":[226],"generally":[229],"well":[230],"balanced":[231],"groups.":[233],"Median":[234],"duration":[236],"10.39":[238],"months":[239],"(23.54":[246],"controls":[250],"(13.15":[251],"months;":[252],"HR=0.48;":[253],"0.31\u20130.72;":[256],"P=.00048).":[257],"Conclusions:":[258],"The":[259,278,392,403,414,425,436,447,458,469,480,491,502,513,1040,1051,1063,1074,1086,1097,1109,1120,1132,1143],"suggest":[264],"greater":[266],"than":[271],"seen":[272],"CENTAUR.":[277,299],"attributed":[281],"aligns":[287],"prior":[289],"analyses":[290],"statistical":[292],"models":[293],"controlling":[294],"for":[295,312,317,330,335,348,353,366,371,384,389,536,555,574,579,592,597,610,615,629,634,647,652,665,670,683,688,701,706,719,724,737,742,755,760,773,778,791,796,809,814,828,833,846,851,864,869,882,887,900,905,918,923,936,947,961,972,985,997,1012,1024],"Disclosure:":[300],"Dr.":[301,319,337,355,373,395,406,417,428,439,450,461,472,483,494,505,516,524,530,543,549,563,581,599,618,636,654,672,690,708,726,744,762,780,798,817,835,853,871,889,907,925,950,974,1001,1034,1043,1054,1066,1077,1089,1100,1112,1123,1135,1146,1154],"Paganoni":[302,320,338,356,374,396,407,418,429,440,451,462,473,484,495,506,517],"has":[303,321,339,357,375,397,408,419,430,441,452,463,474,485,496,507,518,526,532,545,551,565,583,601,620,638,656,674,692,710,728,746,764,782,800,819,837,855,873,891,909,927,952,976,1003,1036,1045,1056,1068,1079,1091,1102,1114,1125,1137,1148,1156],"received":[304,322,340,358,376,398,409,420,431,442,453,464,475,486,497,508,519,533,552,566,584,602,621,639,657,675,693,711,729,747,765,783,801,820,838,856,874,892,910,928,953,977,1004,1046,1057,1069,1080,1092,1103,1115,1126,1138,1149,1157],"personal":[305,323,341,359,377,534,553,567,585,603,622,640,658,676,694,712,730,748,766,784,802,821,839,857,875,893,911,929,954,978,1005],"compensation":[306,324,342,360,378,535,554,568,586,604,623,641,659,677,695,713,731,749,767,785,803,822,840,858,876,894,912,930,955,979,1006],"range":[309,327,345,363,381,571,589,607,626,644,662,680,698,716,734,752,770,788,806,825,843,861,879,897,915,933,958,982,1009],"$500-$4,999":[311,329,347,591,628,646,664,682,700,718,736,754,772,808,827,899,917,960],"serving":[313,331,349,367,385,537,556,575,593,611,630,648,666,684,702,720,738,756,774,792,810,829,847,865,883,901,919,937,962,986,1013],"Consultant":[316,334,352,370,388,578,596,614,633,651,669,687,705,723,741,759,777,795,813,832,850,868,886,904,922],"Cytokinetics.":[318,523],"Jannsen.":[336],"Arrowhead.":[354,888],"$0-$499":[365,383,609,863,881],"Sola.":[372],"Frequency":[390],"Therapeutics.":[391],"institution":[393,404,415,426,437,448,459,470,481,492,503,514,1041,1052,1064,1075,1087,1098,1110,1121,1133,1144],"research":[399,410,421,432,443,454,465,476,487,498,509,520,1047,1058,1070,1081,1093,1104,1116,1127,1139,1150],"support":[400,411,422,433,444,455,466,477,488,499,510,521,1048,1059,1071,1082,1094,1105,1117,1128,1140,1151],"Amylyx.":[402,542,548],"Revalesio.":[413],"Alector.":[424],"UCB.":[435],"Biohaven.":[446,1096],"Clene.":[457],"Prilenia.":[468],"Seelos.":[479,1142],"Calico.":[490,1153],"Denali.":[501],"Anelixis.":[512],"Quintana":[525],"nothing":[527],"disclose.":[529],"Yuehui":[531,544],"employee":[540,559],"stock":[546,1037],"Timmons":[550],"Amylyx":[561],"Pharmaceuticals.":[562],"Cudkowicz":[564,582,600,619,637,655,673,691,709,727,745,763,781,799,818,836,854,872,890,908,926,951,975,1002,1035,1044,1055,1067,1078,1090,1101,1113,1124,1136,1147,1155],"$5,000-$9,999":[573,790],"biogen.":[580],"cytokinetics.":[598],"als":[616],"pharma.":[617],"RRD.":[635],"immunitypharm.":[653],"denali.":[671],"wave.":[689],"transposon.":[707],"Quralis.":[725],"Regeneron.":[743],"LIlly.":[761],"Takeda.":[779],"Faze.":[797],"AB":[815],"sciences.":[816],"MTPC.":[834],"$10,000-$49,999":[845,935,1011],"Neurosense.":[852],"vectorY.":[870],"Servier.":[906],"Eledon.":[924],"Scientific":[940,965],"Advisory":[941,966,1021],"or":[942,967,990,1019],"Data":[943,968],"Safety":[944,969],"Monitoring":[945,970],"board":[946,971],"Locust":[948],"Walk.":[949],"Pasithea.":[973],"$50,000-$99,999":[984],"officer":[989],"member":[991,1032],"Board":[994,1022],"Directors":[996],"Praxis":[998],"Precision":[999],"Medicine.":[1000],"Editor,":[1016,1018],"Associate":[1017],"Editorial":[1020],"Member":[1023],"Annals":[1025],"Neurology":[1027],".":[1028,1062],"An":[1029],"immediate":[1030],"family":[1031],"Sqz.":[1039],"NINDS.":[1050],"ALSA":[1061],"ALSFAC.":[1073],"UCB":[1084],"ra.":[1085],"Clene":[1107],"nanomedicine.":[1108],"prilenia.":[1119],"one.":[1131],"publishing":[1158],"royalties":[1159],"publication":[1162],"relating":[1163],"health":[1165],"care.":[1166]},"counts_by_year":[],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2023-04-29T00:00:00"}